A combined bottom-up/top-down approach to prepare a sterile injectable nanosuspension

被引:28
|
作者
Hu, Xi [1 ]
Chen, Xi [1 ]
Zhang, Ling [1 ]
Lin, Xia [2 ]
Zhang, Yu [1 ]
Tang, Xing [1 ]
Wang, Yanjiao [1 ]
机构
[1] Shenyang Pharmaceut Univ, Dept Pharmaceut, Shenyang, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China
关键词
Nanosuspension; Physical modification; Controlled crystallization; Wettability; High-pressure homogenization; HIGH-PRESSURE HOMOGENIZATION; DRUG NANOCRYSTALS; NANOPARTICLES; FORMULATION; STABILITY; DELIVERY;
D O I
10.1016/j.ijpharm.2014.06.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To prepare a uniform nanosuspension of strongly hydrophobic riboflavin laurate (RFL) allowing sterile filtration, physical modification (bottom-up) was combined with high-pressure homogenization (top-down) method. Unlike other bottom-up approaches, physical modification with surfactants (TPGS and PL-100) by lyophilization controlled crystallization and compensated for the poor wettability of RFL. On one hand, crystal growth and aggregation during freezing was restricted by a stabilizer-layer adsorbed on the drug surface by hydrophobic interaction. On the other hand, subsequent crystallization of drug in the sublimation process was limited to the interstitial spaces between solvent crystals. After lyophilization, modified drug with a smaller particle size and better wettability was obtained. When adding surfactant solution, water molecules passed between the hydrophilic groups of surface active Molecules and activated the polymer chains allowing them to stretch into water. The coarse suspension was crushed into a nanosuspension (MP=162 nm) by high-pressure homogenization. For long term stability, lyophilization was applied again to solidify the nanosuspension (sorbitol as cryoprotectant). A slight crystal growth to about 600 nm was obtained to allow slow release for a sustained effect after muscular administration. Moreover, no paw-licking responses and very slight muscular inflammation demonstrated the excellent biocompatibility of this long-acting RFL injection. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:130 / 139
页数:10
相关论文
共 50 条
  • [41] Top-down and bottom-up quality management
    Hurst, Keith
    INTERNATIONAL JOURNAL OF HEALTH CARE QUALITY ASSURANCE, 2010, 23 (07) : 16 - 17
  • [42] Top-down and bottom-up research in biodemography
    Kaplan, Hillard
    Gurven, Michael
    DEMOGRAPHIC RESEARCH, 2008, 19 : 1587 - 1602
  • [43] Bottom-Up and Top-Down Graph Pooling
    Yang, Jia-Qi
    Zhan, De-Chuan
    Li, Xin-Chun
    ADVANCES IN KNOWLEDGE DISCOVERY AND DATA MINING, PAKDD 2020, PT II, 2020, 12085 : 568 - 579
  • [44] When bottom-up meets top-down
    Dittrich, W
    TRENDS IN COGNITIVE SCIENCES, 2001, 5 (04) : 137 - 137
  • [45] Nanotechnology -: Bottom-up meets top-down
    Schmidt, OG
    Deneke, C
    Nakamura, Y
    Zapf-Gottwick, R
    Müller, C
    Jin-Phillipp, NY
    ADVANCES IN SOLID STATE PHYSICS 42, 2002, 42 : 231 - 240
  • [46] A top-down look at bottom-up electronics
    Lundstrom, M
    2003 SYMPOSIUM ON VLSI CIRCUITS, DIGEST OF TECHNICAL PAPERS, 2003, : 5 - 8
  • [47] Shadow processing: Top-down or bottom-up?
    Porter, G.
    Tales, A.
    Troscianko, T.
    Leonards, U.
    PERCEPTION, 2007, 36 : 161 - 161
  • [48] When bottom-up meets top-down
    Shtein, Zvi
    Shoseyov, Oded
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (03) : 428 - 429
  • [49] Bottom-up versus top-down lawmaking
    Rachlinski, Jeffrey J.
    UNIVERSITY OF CHICAGO LAW REVIEW, 2006, 73 (03): : 933 - 964
  • [50] Top-down and bottom-up image processing
    Stark, LW
    Privitera, C
    1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, 1997, : 2294 - 2299